BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

e vs mg

Mechanistic comparison of e 64 and mg 132 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

4
Shared Targets
31%
Jaccard Similarity
29%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

e 64
Evidence Score
0
PubMed Studies
View full profile →
mg 132
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

e and mg share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.308 means 31% of the combined target set is bound by both compounds. The IDF-weighted score of 0.285 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do e and mg have in common?
e and mg share 4 molecular targets with a Jaccard similarity of 31%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can e and mg be combined?
e and mg share 4 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: e or mg?
In the BiohacksAI corpus: e has 0 PubMed-indexed studies, mg has 0 studies.

Related Comparisons

Similar to e

e vs calpeptin4 targetse vs cyano4 targetse vs balicatib4 targetse vs e3 targetse vs odanacatib4 targets

Similar to mg

mg vs marizomib3 targetsmg vs ixazomib3 targetsmg vs calpeptin3 targetsmg vs epoxomycin3 targetsmg vs cyano3 targets
View full e profile →View full mg profile →Browse all substances →